Scientists test new drug duo to control blood cancer without chemotherapy
NCT ID NCT03789240
Summary
This study is testing whether a combination of two drugs, copanlisib and rituximab, can effectively control follicular lymphoma in people who have not yet received treatment. The goal is to see if this drug duo can lead to deep and lasting remissions without using traditional chemotherapy. The treatment is given through an IV, and researchers will closely monitor how well the cancer responds and for how long.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.